Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;25(6):1087-1095.
doi: 10.1007/s11154-024-09886-w. Epub 2024 May 18.

The relationship between low prolactin and type 2 diabetes

Affiliations
Review

The relationship between low prolactin and type 2 diabetes

Gie Ken-Dror et al. Rev Endocr Metab Disord. 2024 Dec.

Abstract

Prolactin (PRL) is secreted throughout life in men and women. At elevated levels, its physiological role in pregnancy and lactation, and pathological effects, are well known. However clinical implications of low circulating PRL are not well established. We conducted a meta-analysis to examine the relationship between low PRL levels and type 2 diabetes. Five papers included cross-sectional studies comprising 8,720 men (mean age range 51.4-60 years) and 3,429 women (49.5-61.6 years), and four papers included cohort studies comprising 2,948 men (52.1-60.0 years) and 3,203 women (49.2-60.1 years). Individuals with pregnancy, lactation and hyperprolactinemia, drugs known to alter circulating PRL levels, or pituitary diseases had been excluded. Although most studies used quartiles to categorize PRL groups for analysis, PRL cut-off values (all measured by chemiluminescence immunoassay) were variably defined between studies: the lowest PRL quartiles ranged from 3.6 ng/ml to 7.2 ng/ml in men and between 4.5 ng/ml to 8 ng/ml in women; and the highest PRL quartiles ranged from 6.9 ng/ml to 13 ng/ml in men and 9.6 ng/ml to 15.8 ng/ml in women. Type 2 diabetes was defined variably using self-reported physician's diagnosis, fasting blood glucose, oral glucose tolerance test or glycated hemoglobin (HbA1C). In cross-sectional studies, compared to individuals in the highest PRL groups (reference), those in the lowest PRL groups had greater risk of type 2 diabetes both in men: odds ratio (OR) and 95% confidence interval = 1.86 (1.56-2.22) and in women: OR = 2.15 (1.63-2.85). In cohort studies, women showed a significant association between low PRL and type 2 diabetes: OR = 1.52 (1.02-2.28) but not men: OR = 1.44 (0.46-4.57). Relatively low heterogeneity was observed (I2 = 25-38.4%) for cross-sectional studies, but higher for cohort studies (I2 = 52.8-79.7%). In conclusion, low PRL is associated with type 2 diabetes, but discrepancy between men and women in the relationship within cohort studies requires further research.

Keywords: Hypoprolactinemia; Meta-analysis; Sex-specific analysis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Conflict of interest statement: The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Flow chart of literature search and study selection process
Fig. 2
Fig. 2
Association between individuals with low levels of PRL and type 2 diabetes reported in cross-sectional studies (A), and risk of developing type 2 diabetes amongst individuals with low PRL levels at baseline reported in cohort studies (B). Group of individuals with high levels of PRL within physiological range were used as reference (see Table 1 for PRL cut-off values from primary studies). Note: CI, confidence interval; df, degrees of freedom; P, probability

References

    1. Bernard V, Young J, Binart N. Prolactin - a pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019;15(6):356–65. 10.1038/s41574-019-0194-6. - PubMed
    1. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523–631. 10.1152/physrev.2000.80.4.1523. - PubMed
    1. Grattan DR. 60 years of neuroendocrinology: The hypothalamo-prolactin axis. J Endocrinol. 2015;226(2):T101–22. 10.1530/JOE-15-0213. - PMC - PubMed
    1. Serri O, Chik CL, Ur E, Ezzat S. Diagnosis and management of hyperprolactinemia. CMAJ. 2003;169(6):575–81. - PMC - PubMed
    1. Edinoff AN, Silverblatt NS, Vervaeke HE, et al. Hyperprolactinemia, clinical considerations, and infertility in women on antipsychotic medications. Psychopharmacol Bull. 2021;51(2):131. - PMC - PubMed

LinkOut - more resources